March 27th 2012
“Using Viruses to Beat Superbugs,” AmpliPhi CSO Dr. David Harper featured in ScienceDaily
Read full article...March 08th 2012
“The Bacteriophage Comes of Age” in Medscape News
Read full article...January 31st 2012
January 2012 Shareholder Letter
Read full article...January 04th 2012
BioWorld Today features AmpliPhi CEO Phil Young
Read full article...November 21st 2011
AmpliPhi Biosciences Announces First Closing of $2.7m
Read full article...November 08th 2011
AmpliPhi Biosciences appoints Philip J. Young as President and CEO
Read full article...September 06th 2011
AmpliPhi Biosciences to Present at Rodman & Renshaw Annual Global Investment Conference in New York
Read full article...August 09th 2011
Edison Investment Research releases “Antibiotic Amplifier”, an assessment of AmpliPhi Biosciences
Read full article...July 14th 2011
Scientists Explore Alternative to Antibiotics
Read full article...April 11th 2011
AmpliPhi Biosciences Announces UK Grant Award to develop its Novel Antimicrobial Technology
Read full article...March 09th 2011
Targeted Genetics Announces Name Change to AmpliPhi Biosciences and Highlights Strategic Development
Read full article...Events
May 09th 2012
Prof. Mark Enright “Taking a Zero Tolerance Approach to Preventable Surgical Site Infection”
MoreApril 17th 2012
Dr. David Harper at the CHI Antibacterial Drug Development Meeting
MoreMarch 26th 2012
Dr. David Harper at Society for General Microbiology Spring Conference 2012
MoreMarch 12th 2012
Professor Mark Enright to present at University of Bath
MoreMarch 12th 2012
Professor Mark Enright to present at University of Bath
More